Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Updating the evidence relating smoking bans to incidence of heart disease.

Lee PN, Fry JS, Thornton AJ.

Regul Toxicol Pharmacol. 2019 Feb;101:172-186. doi: 10.1016/j.yrtph.2018.11.014. Epub 2018 Nov 27. Review.

2.

Modeling the impact of changes in tobacco use on individual disease risks.

Djurdjevic S, Sponsiello-Wang Z, Lee PN, Fry JS, Weitkunat R, L├╝dicke F, Baker G.

Regul Toxicol Pharmacol. 2018 Aug;97:88-97. doi: 10.1016/j.yrtph.2018.06.001. Epub 2018 Jun 9.

PMID:
29894733
3.

Investigation into the risk of ultra-low tar cigarettes and lung cancer.

Lee PN, Fry JS, Hamling JS.

Regul Toxicol Pharmacol. 2017 Oct;89:112-117. doi: 10.1016/j.yrtph.2017.07.023. Epub 2017 Jul 25.

4.

Estimating the effect of differing assumptions on the population health impact of introducing a Reduced Risk Tobacco Product in the USA.

Lee PN, Fry JS, Hamling JF, Sponsiello-Wang Z, Baker G, Weitkunat R.

Regul Toxicol Pharmacol. 2017 Aug;88:192-213. doi: 10.1016/j.yrtph.2017.06.009. Epub 2017 Jun 24.

5.

Is the shape of the decline in risk following quitting smoking similar for squamous cell carcinoma and adenocarcinoma of the lung? A quantitative review using the negative exponential model.

Fry JS, Lee PN, Forey BA, Coombs KJ.

Regul Toxicol Pharmacol. 2015 Jun;72(1):49-57. doi: 10.1016/j.yrtph.2015.02.010. Epub 2015 Feb 20.

6.

A review of the evidence on smoking bans and incidence of heart disease.

Lee PN, Fry JS, Forey BA.

Regul Toxicol Pharmacol. 2014 Oct;70(1):7-23. doi: 10.1016/j.yrtph.2014.06.014. Epub 2014 Jun 20. Review.

7.

Estimating the decline in excess risk of chronic obstructive pulmonary disease following quitting smoking - a systematic review based on the negative exponential model.

Lee PN, Fry JS, Forey BA.

Regul Toxicol Pharmacol. 2014 Mar;68(2):231-9. doi: 10.1016/j.yrtph.2013.12.006. Epub 2013 Dec 19. Review.

8.

Estimating the decline in excess risk of cerebrovascular disease following quitting smoking--a systematic review based on the negative exponential model.

Lee PN, Fry JS, Thornton AJ.

Regul Toxicol Pharmacol. 2014 Feb;68(1):85-95. doi: 10.1016/j.yrtph.2013.11.013. Epub 2013 Nov 26. Review.

9.

The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes.

Forey BA, Fry JS, Lee PN, Thornton AJ, Coombs KJ.

Biomark Res. 2013 Sep 13;1(1):26. doi: 10.1186/2050-7771-1-26.

10.

How rapidly does the excess risk of lung cancer decline following quitting smoking? A quantitative review using the negative exponential model.

Fry JS, Lee PN, Forey BA, Coombs KJ.

Regul Toxicol Pharmacol. 2013 Oct;67(1):13-26. doi: 10.1016/j.yrtph.2013.06.001. Epub 2013 Jun 10.

11.

Systematic review with meta-analysis of the epidemiological evidence relating FEV1 decline to lung cancer risk.

Fry JS, Hamling JS, Lee PN.

BMC Cancer. 2012 Oct 27;12:498. doi: 10.1186/1471-2407-12-498. Review.

12.

Using the negative exponential distribution to quantitatively review the evidence on how rapidly the excess risk of ischaemic heart disease declines following quitting smoking.

Lee PN, Fry JS, Hamling JS.

Regul Toxicol Pharmacol. 2012 Oct;64(1):51-67. doi: 10.1016/j.yrtph.2012.06.009. Epub 2012 Jun 21. Review.

13.

Reassessing the evidence relating smoking bans to heart disease.

Lee PN, Fry JS.

Regul Toxicol Pharmacol. 2011 Dec;61(3):318-31. doi: 10.1016/j.yrtph.2011.09.002. Epub 2011 Sep 17.

14.

Systematic review of the evidence relating FEV1 decline to giving up smoking.

Lee PN, Fry JS.

BMC Med. 2010 Dec 14;8:84. doi: 10.1186/1741-7015-8-84. Review.

15.

Does use of flue-cured rather than blended cigarettes affect international variation in mortality from lung cancer and COPD?

Lee PN, Forey BA, Fry JS, Hamling JS, Hamling JF, Sanders EB, Carchman RA.

Inhal Toxicol. 2009 Apr;21(5):404-30. doi: 10.1080/08958370802317737.

PMID:
19496695
16.

2-Methoxy antimycin reveals a unique mechanism for Bcl-x(L) inhibition.

Schwartz PS, Manion MK, Emerson CB, Fry JS, Schulz CM, Sweet IR, Hockenbery DM.

Mol Cancer Ther. 2007 Jul;6(7):2073-80.

17.

Perceived prevalence of peanut allergy in Great Britain and its association with other atopic conditions and with peanut allergy in other household members.

Emmett SE, Angus FJ, Fry JS, Lee PN.

Allergy. 1999 Apr;54(4):380-5. Erratum in: Allergy 1999 Aug;54(8):891.

PMID:
10371098
19.

Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis.

Lewis HM, Renaula TL, Garioch JJ, Leonard JN, Fry JS, Collin P, Evans D, Fry L.

Br J Dermatol. 1996 Sep;135(3):363-7.

PMID:
8949426
20.

Estimating age, sex and period specific constant tar cigarette consumption in the UK.

Lee PN, Fry JS, Forey BA.

Thorax. 1993 Jun;48(6):679. No abstract available.

21.
22.

A stratified Wilcoxon-type test for trend.

Fry JS, Lee PN.

Stat Med. 1991 May;10(5):799-800. No abstract available.

PMID:
1898482
23.
24.

Large bowel cancer: the effect of perioperative blood transfusion on outcome.

Cheslyn-Curtis S, Fielding LP, Hittinger R, Fry JS, Phillips RK.

Ann R Coll Surg Engl. 1990 Jan;72(1):53-9.

25.

Prediction of outcome after curative resection for large bowel cancer.

Fielding LP, Phillips RK, Fry JS, Hittinger R.

Lancet. 1986 Oct 18;2(8512):904-7.

PMID:
2876336
26.

Influence of tumour site on presentation, management and subsequent outcome in large bowel cancer.

Aldridge MC, Phillips RK, Hittinger R, Fry JS, Fielding LP.

Br J Surg. 1986 Aug;73(8):663-70.

PMID:
3742184
27.

Malignant large bowel obstruction.

Phillips RK, Hittinger R, Fry JS, Fielding LP.

Br J Surg. 1985 Apr;72(4):296-302.

PMID:
3986481
28.

Large bowel cancer: surgical pathology and its relationship to survival.

Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP.

Br J Surg. 1984 Aug;71(8):604-10.

PMID:
6743980
29.
30.

Dust exposure and mortality in an American chrysotile asbestos friction products plant.

McDonald AD, Fry JS, Woolley AJ, McDonald JC.

Br J Ind Med. 1984 May;41(2):151-7.

31.

Prescribing--a suitable case for treatment.

Harris CM, Jarman B, Woodman E, White P, Fry JS.

J R Coll Gen Pract Occas Pap. 1984 Jan;(24):1-39. No abstract available.

32.

Local recurrence following 'curative' surgery for large bowel cancer: II. The rectum and rectosigmoid.

Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP.

Br J Surg. 1984 Jan;71(1):17-20.

PMID:
6689963
33.

Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture.

Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP.

Br J Surg. 1984 Jan;71(1):12-6.

PMID:
6689962
34.
35.

Dust exposure and mortality in an American chrysotile textile plant.

McDonald AD, Fry JS, Woolley AJ, McDonald J.

Br J Ind Med. 1983 Nov;40(4):361-7.

36.

Expression of bacterial genes in plant cells.

Fraley RT, Rogers SG, Horsch RB, Sanders PR, Flick JS, Adams SP, Bittner ML, Brand LA, Fink CL, Fry JS, Galluppi GR, Goldberg SB, Hoffmann NL, Woo SC.

Proc Natl Acad Sci U S A. 1983 Aug;80(15):4803-7.

37.

Hyaline ascospores as a cause of the epidemic of asthma deaths in the 1960s.

Ackroyd JF, Fry JS.

Clin Allergy. 1983 May;13(3):287-90. No abstract available.

PMID:
6851076
38.

Increased incidence of malignancy in dermatitis herpetiformis.

Leonard JN, Tucker WF, Fry JS, Coulter CA, Boylston AW, McMinn RM, Haffenden GP, Swain AF, Fry L.

Br Med J (Clin Res Ed). 1983 Jan 1;286(6358):16-8.

39.

Mesothelioma and the fiber type in three American asbestos factories - preliminary report.

McDonald AD, Fry JS.

Scand J Work Environ Health. 1982;8 Suppl 1:53-8.

40.

Comparison of multiple puncture liquid tuberculin test with Mantoux test.

Lunn JA, Johnson AJ, Fry JS.

Lancet. 1981 Mar 28;1(8222):695-8.

PMID:
6110916
41.

Funding of employee benefits.

Ostuw R, Fry JS.

Top Health Care Financ. 1980 Spring;6(3):35-50. No abstract available.

PMID:
7376183

Supplemental Content

Support Center